Concepedia

Debbie Higgins

DH

5

Publications

263

Citations

5

H-Index

2002

Active since

Affiliations

Dynavax Technologies (United States)(Current)

Dynavax Technologies (Germany)

Debbie Higgins is an author at Dynavax Technologies (United States) specializing in medicine, immunology, and pathogenesis.

Top concepts

Publications per year

2002–2012

5

Publications

5

Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection

Richard B. Pyles, Debbie Higgins, Claudia Chalk et al. · Journal of Virology · 2002 · 109 citations · Full text

Superior Activity of the Type C Class of ISS <i>In Vitro</i> and <i>In Vivo</i> Across Multiple Species

Jason D. Marshall, Karen L. Fearon, Debbie Higgins et al. · DNA and Cell Biology · 2005 · 76 citations

Encapsulating Immunostimulatory CpG Oligonucleotides in Listeriolysin O-Liposomes Promotes a Th1-Type Response and CTL Activity

Chasity D. Andrews, Myung-Sook Huh, Kathryn Patton et al. · Molecular Pharmaceutics · 2012 · 34 citations · Full text

, , +24

Polymyxin B enhances ISS-mediated immune responses across multiple species

Jason D. Marshall, Debbie Higgins, Christi Abbate et al. · Cellular Immunology · 2004 · 26 citations

, , +5

Evolving Strategies for the Prevention of Influenza Infection

Brian Livingston, Debbie Higgins, Gary Van Nest · BioDrugs · 2006 · 18 citations · Full text

, , +5

Rows per page

1–5 of 5